Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rameda is a leading Egyptian pharmaceutical company that specializes in the manufacturing and marketing of a wide range of generic medicines. Established in 1986, the company operates state-of-the-art production facilities in 6th of October City, covering various dosage forms including solids, liquids, and injectables. Rameda's portfolio spans multiple therapeutic areas such as anti-infectives, cardiovascular, and central nervous system treatments. The company is publicly listed on the Egyptian Exchange and serves both the domestic Egyptian market and various export markets across the Middle East and Africa. Its business model focuses on identifying high-growth therapeutic areas and launching high-quality, affordable generic alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rameda Pharmaceutical Company.